Coronary Artery Calcium Score-Directed Primary Prevention With Statins on the Basis of the 2018 American College of Cardiology/American Heart Association/Multisociety Cholesterol Guidelines

Jana Taron, Asya Lyass, Taylor F Mahoney, Rachel Q Ehrbar, Ramachandran S Vasan, Ralph B D'Agostino Sr, Udo Hoffmann, Joseph M Massaro, Michael T Lu, Jana Taron, Asya Lyass, Taylor F Mahoney, Rachel Q Ehrbar, Ramachandran S Vasan, Ralph B D'Agostino Sr, Udo Hoffmann, Joseph M Massaro, Michael T Lu

No abstract available

Keywords: 2018 multisociety guidelines on cholesterol management; coronary artery calcium; primary prevention; statin.

Conflict of interest statement

Dr Hoffmann reports receiving research support on behalf of his institution from Duke University (Abbott), HeartFlow, Kowa Company Limited, and MedImmune/Astrazeneca; and receiving consulting fees from Duke University (National Institutes of Health) and Recor Medical, unrelated to this research. Dr Lu reports research funding from the American Heart Association (18UNPG34030172 and 810966), research funding from the Nvidia Corporation Academic Program, research funding as a coinvestigator to Massachusetts General Hospital from Kowa Company Limited and Medimmune/Astrazeneca, and receiving personal fees from PQBypass, unrelated to this work. Dr. Taron reports funding by Deutsche Forschungsgesellschaft (DFG, German Research Foundation) – TA 1438/1‐2; and speakers bureau Siemens Healthcare GmbH, unrelated to this work. The remaining authors have no disclosure to report.

References

    1. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella‐Tommasino J, Forman DE, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082–e1143.
    1. Hoffmann U, Massaro JM, Fox CS, Manders E, O’Donnell CJ. Defining normal distributions of coronary artery calcium in women and men (from the Framingham Heart Study). Am J Cardiol. 2008;102:1136–1141.e1.
    1. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi‐Ethnic Study of Atherosclerosis (MESA). Circulation. 2006;113:30–37.
    1. Pursnani A, Massaro JM, D’Agostino RB, O’Donnell CJ, Hoffmann U. Guideline‐based statin eligibility, coronary artery calcification, and cardiovascular events. JAMA. 2015;314:134.
    1. Nasir K, Bittencourt MS, Blaha MJ, Blankstein R, Agatson AS, Rivera JJ, Miedema MD, Sibley CT, Shaw LJ, Blumenthal RS, et al. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines. J Am Coll Cardiol. 2015;66:1657–1668.
    1. Dzaye O, Dardari ZA, Cainzos‐Achirica M, Blankstein R, Szklo M, Budoff MJ, Lima JAC, Blumenthal RS, Nasir K, Blaha MJ. Incidence of new coronary calcification: time to conversion from CAC = 0. J Am Coll Cardiol. 2020;75:1610–1613.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere